Delivery Order SPE2DB20D3101-SPE2DB21FK5A2

Award Date 9/13/21
Potential Completion Date 9/14/21
Potential Value $1.7K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,085.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is a Delivery Order contract for the supply of Metoprolol Succinate Extended-Release 50 mg tablets. The contract has a period of performance through January 4, 2024 and uses a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $1,503.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of 4,565,683,361 units of Metoprolol Succinate Extended-Release 100 mg tablets. This is a firm-fixed price delivery order contract with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, leverages its extensive supply chain to provide a wide range of essential medical...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of 4,565,802,734 units of Metoprolol Succinate Extended-Release 100 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,308.84 and a period of performance through September 16, 2024. AmerisourceBergen, a for-profit organization, is not subject to any set-aside requirements for this award. The company...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $1,237.68 firm fixed price delivery order is for the supply of 4,566,307,621 tablets of the cardiovascular medication Metoprolol Succinate Extended Release 100 mg. The contract has a completion date of November 4, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical products and supplies to...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,564,987,303 units of Metoprolol Succinate Extended-Release 50 mg Tablets in 1,000-count bottles. The award has a Firm Fixed Price and a total ceiling value of $10,017.50. This is not a Set-Aside contract. Amerisourcebergen is a major pharmaceutical distribution company that holds a single-award Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Bisoprolol Fumarate 5 mg tablets to the Defense Logistics Agency (DLA). The $1,296.61 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,025.79 firm fixed-price delivery order contract is for the supply of TOPROL XL 25 MG tablets to support military healthcare programs. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,560,878,450 tablets of Metoprolol Succinate Extended-Release 50 mg. The contract has a ceiling value of $1,571.76 and a completion date of May 10, 2023. This contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of pharmaceutical products and medical supplies to support TRICARE, the military healthcare program. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $83,840.05 firm fixed price delivery order has a completion date of May 23, 2019. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA...
This federal contract award is for the delivery of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $124,691.86, is a firm fixed-price delivery order that does not have a set-aside designation, indicating open competition. It covers a broad...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB21FK5A2
    Delivery Order

This federal contract award is for the delivery of Metoprolol Succinate ER 25 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,740.50 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., which is a major pharmaceutical distributor.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. There was no set-aside designation for this specific award.

Generated 2/27/25, 10:20 AM